2021
DOI: 10.1186/s41927-021-00203-5
|View full text |Cite
|
Sign up to set email alerts
|

Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement?

Abstract: Background Ocular manifestations are common in systemic lupus erythematosus (SLE). Retinopathy has previously been linked to disease severity and might have a significant impact on the patient’s quality of life and has also been associated with a poor prognosis in SLE. This study aimed to determine the prevalence of retinopathy among patients who are newly diagnosed with SLE. Methods In a cross-sectional study, patients diagnosed with SLE at a tert… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 18 publications
0
0
0
Order By: Relevance
“…Interestingly, Bashiri, H. et al . [ 16 ] found a relatively high rate of retinopathy in patients with SLE at the time of their initial diagnosis, even suggesting the need for ocular screening at the time of diagnosis in patients with severe disease. Prospective studies are needed for evaluating the associations between retinopathy and disease activity and prognostic indicators for ocular involvement.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, Bashiri, H. et al . [ 16 ] found a relatively high rate of retinopathy in patients with SLE at the time of their initial diagnosis, even suggesting the need for ocular screening at the time of diagnosis in patients with severe disease. Prospective studies are needed for evaluating the associations between retinopathy and disease activity and prognostic indicators for ocular involvement.…”
Section: Discussionmentioning
confidence: 99%
“…Early retinopathy detection is crucial to prevent vision-threatening complications. The timetable for HCQ toxicity screening, for patients with no risk factors, includes baseline fundus examination to detect coexistent retinal disease and annual screening after 5 years from SLE diagnosis [ 6 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hydroxychloroquine therapy is considered safe with good disease control but associated with dose-dependent toxicity [6]. Hydroxychloroquine retinopathy tends to increase with long-term therapy (5 or more years), high daily dose (more than 5 mg/kg per day), chronic renal disease, use of tamoxifen and preexisting retinal or macular disease [6][7][8].…”
Section: Cst -Central Subfield Thickness Gcl -Ganglion Cell Layer Oct...mentioning
confidence: 99%
See 1 more Smart Citation
“…The most common manifestation of SLE is arthritis which is seen in almost half the patients with SLE, followed by malar rash [2]. Of note, SLE is a multisystem Reumatologia 2023; 61/5 disorder that affects multiple organs and can have varying presentations such as pericarditis, central nervous system disturbances, nephropathy, retinopathy and gastrointestinal symptoms [2][3][4][5]. Moreover, psychiatric manifestations including depression and anxiety are commonly seen in SLE patients [6].…”
Section: Introductionmentioning
confidence: 99%